EOS imaging is a global medical device company that develops and markets advanced imaging and imaged-based solutions for diagnosing, treating and monitoring the most common musculoskeletal pathologies.

The company is challenging the status quo in orthopedic imaging, offering 2D and 3D precision at a low dose and championing a new patient-specific standard of care…

  • Because so many people are afflicted by musculoskeletal conditions and looking for better outcomes
  • Because patients deserve safe exams at the lowest radiation dose possible
  • Because bodies are 3D and weight-bearing so medical images should be too
  • Because the spine, hips and knees need to be looked at as a global system, not separately

For all these reasons and more, EOS imaging develops and markets its full body, low dose medical imaging system (EOS), 2D/3D workstation (sterEOS) and a suite of online, 3D surgical planning solutions for the spine, hip and knee (EOSapps).

We strive to ‘connect imaging to care’.

 

Our History

Our company originates from scientific research on radiation detection that was awarded the Nobel Prize in Physics in 1992. Since then, world-class physicists, engineers, radiologists and surgeons have worked together to transform science into technology. The result was an imaging solution that addressed the specific needs for skeletal imaging: a fast, full body imaging system that offers low dose and the ability to generate 3D images and data.

By 2008, the first EOS systems were installed in Europe and North America. In 2012, EOS imaging became a publicly traded company on Euronext Paris (EOSI). Today, the EOS platform is available in 51 countries, including the United States, Japan, China and the European Union. The company is based in Paris and has five subsidiaries in Besançon (France), Cambridge (USA), Montréal (Canada), Frankfurt (Germany) and Singapore.

Events

JFR 2017

Fri, 13 Oct 2017 - Mon, 16 Oct 2017


Place de la Porte Maillot 2
Paris, Île-de-France 75017
France
RSNA 2017: Radiological Society of North America Conference

Sun, 26 Nov 2017 - Fri, 1 Dec 2017


South Lake Shore Drive 2301
Chicago, Illinois 60616
United States
IPOS 2017

Tue, 28 Nov 2017 - Sat, 2 Dec 2017


Hollywood Way 6300
Orlando, Florida 32819
United States
12. Jahrestagung der Deutschen Wirbelsäulengesellschaft

Thu, 30 Nov 2017 - Sat, 2 Dec 2017


Messepiazza 1
Leinfelden-Echterdingen, Baden-Württemberg 70629
Germany

News

IMAGING Management

EOS imaging reports first half 2017 financial results

2017 11 Sep

16% sales growth driven by positive momentum in EMEA and APAC regionsNew North America leadership and organizational structure to rapidly improve Company’s performance in this key marketImproving equity and cash positionsEOS imaging (Paris:EOSI)(Euronext, FR0011191766 – EOSI - Eligible PEA - SME), the pioneer in 2D/3D orthopedic medical imaging, has... Read more

IMAGING Management

EOS imaging Introduces Personalized Biomechanical Simulation in Spine Surgery Planning

2017 05 Sep

New spineEOS software to be presented during a symposium at the Scoliosis Research Society (SRS) Annual MeetingEOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, today announced that it will introduce a new version of spineEOS, the Company’s online 3D planning software for spine surgery based on... Read more

IMAGING Management

EOS imaging Reports 16% Revenue Growth for the First Half 2017

2017 19 Jul

Strong growth in EMEA and Asia-PacificNew organization in North AmericaEOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - SME), the pioneer of orthopaedic medical imaging, 2D/3D, has announced its (non-audited) consolidated revenue for the first semester ended June 30, 2017.Marie Meynadier, Chief Executive Officer of EOS imaging,... Read more

IMAGING Management

EOS imaging Appoints Mike Lobinsky to Newly Created Position of President, North America

2017 18 Jul

Proven executive experienced in orthopedics and medical imaging will lead next steps in the company’s development in North AmericaEOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, has announced the appointment of Mike Lobinsky to the newly created position of President, North America. In this... Read more

IMAGING Management

EOS imaging Appoints Pierre Schwich as Chief Financial Officer

2017 17 Jul

EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopaedic medical imaging, has announced the appointment of Pierre Schwich as Chief Financial Officer (CFO), effective immediately.Marie Meynadier, CEO of EOS imaging, says: “We are pleased to welcome Pierre to our team. His extensive experience with healthcare and technology... Read more

IMAGING Management

EOS Imaging Announces the Installation of the 50th EOS® System in France

2017 02 May

The EOS® solution is now available at the Villeneuve d’Ascq Private Hospital site, a member of the Ramsay Générale de Santé group   EOS imaging (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, has announced the 50 th installation of an EOS® system in France at the Imanord medical imaging center in the Hôpital Privé Villeneuve... Read more

IMAGING Management

EOS Imaging Announces Opening of First Two EOS® Systems in China

2017 25 Apr

Nanjing Drum Tower Hospital and Ruijin Hospital first facilities to install EOS systems in the country   EOS imaging (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3Dorthopedic medical imaging, has announced the first two installations of EOS systems in China at NanjingDrum Tower Hospital and Ruijin Hospital.   Nanjing Drum Tower Hospital, Affiliated... Read more

IMAGING Management

EOS imaging Raises c. €7.8m in a Private Placement

2017 22 Apr

EOS imaging (Euronext, FR0011191766– EOSI), (the “Company”), pioneer in 2D/3D orthopaedic medical imaging, has announced the completion of a private placement in favour of domestic and international investors conducted by way of an accelerated book build offering. The Company has placed 1,868,000 new shares at a nominal value of €0.01, for a price of... Read more

IMAGING Management

EOS Imaging Launches a Capital Increase Through a Private Placement

2017 21 Apr

EOS imaging (Euronext, FR0011191766 – EOSI) (the “Company”), pioneer in 2D/3D orthopaedic medical imaging, has announced the launch of a capital increase by issuance of new shares without pre-emptive rights in favour of qualified investors, in accordance with the 11th and 12th resolutions of the shareholder’s extraordinary general meeting held on June... Read more

IMAGING Management

EOS Imaging Reports 34% Revenue Growth for the First Quarter of 2017

2017 13 Apr

High Growth driven by continued expansion in EMEA and building momentum in Asia-Pacific   EOS imaging (Euronext, FR0011191766 – EOSI – Eligible for PEA-PME savings schemes in France), the pioneer in 2D/3D orthopaedic medical imaging, has announced its consolidated revenue for the first quarter ended March 31, 2017.   Marie Meynadier, Chief Executive... Read more

IMAGING Management

EOS imaging Announces First Sale of EOS System in Israel

2017 06 Apr

Tel Aviv Sourasky Medical Center first to offer the unique benefits of the EOS technology to patients in Israel   EOS imaging (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, has announced the first sale of an EOS platform in Israel to Tel Aviv Sourasky Medical Center. The EOS platform has now been sold in 33 countries.... Read more

IMAGING Management

EOS imaging Reports Full Year 2016 Results

2017 23 Mar

2016 revenue of €30.8 million, up 41%2016 operating loss reduced by 31% to €4.6 millionCash position: €14.9 million at December 31, 2016 EOS imaging (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, has announced consolidated results for the full year ended December 31, 2016, as approved by the Board of Directors on March... Read more

IMAGING Management

New presentations and recent additions to EOS Product Offering to be featured at AAOS Annual Meeting

2017 17 Mar

Several oral presentations reinforce value of EOS 3D imaging and hipEOS software in total hip arthroplasty Company to present at Canaccord Genuity Musculoskeletal Conference during AAOS EOS imaging (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging,has announced it will exhibit its full EOSapps software suite at the upcoming... Read more

IMAGING Management

EOS imaging Announces Third Sale into Nemours Children’s Health System

2017 10 Mar

Nemours Children’s Flagship Hospital in Orlando has acquired an EOS system  EOS imaging (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, has announced the sale of the third EOS system into the Nemours Children’s Health System. The EOS system was ordered by Nemours Children’s Hospital in Orlando, Florida, one of the two... Read more

IMAGING Management

EOS Imaging 2016 Revenue Increases 41% to €30.8 million

2017 18 Jan

– EOS imaging (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopaedic medical imaging, announces its consolidated revenue for the fourth quarter and full year ended December 31, 2016.  Marie Meynadier, CEO of EOS imaging, said: “In 2016 we delivered a strong year of execution of our growth strategy. At a commercial level, our teams and partners... Read more

IMAGING Management

EOS imaging Announces Exclusive Licensing and Partnership in Surgical Simulation

2016 21 Jan

EOS imaging (Paris:EOSI)(Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, has announced a new partnership with Montreal-based Spinologics to develop a biomechanical simulation software dedicated to spine surgery planning that will be integrated into EOS imaging’s cloud-based, 3D planning software. The co-development will... Read more

IMAGING Management

EOS imaging Announces €21.8 Million 2015 Revenue

2016 07 Jan

Stable sales of equipment impacted by the last quarterStrong growth in North AmericaEOS imaging (Paris:EOSI), the pioneer in 2D/3D orthopaedic medical imaging has announces its consolidated revenue for the fourth quarter and full year ended December 31, 2015.In millions of euros     2014   2013    Change (%)Equipment sales   &nb Read more

IMAGING Management

2015 21 Dec

While at RSNA 2015, HealthManagement.org’s Zoom On met up with Jamie Milas, recently appointed Vice President of Marketing at EOS imaging.  1. What are your key areas of interest and research/assignment?  I am interested in proving  the clinical value of using 3D information for patient-specific diagnostic and surgical planning, to discover ways to... Read more

IMAGING Management

EOS imaging Clinical Study on Elderly Patients’ Fall Risk Prevention

2015 15 Dec

Study findings correlate the risk of falling with postural balance measured from EOS examsEOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, has announced the first clinical results from a study designed to determine the correlation between certain sagittal balance measurements and the risk of... Read more

IMAGING Management

EOS Imaging Announces Record 6 Installations in the US in Last Month

2015 09 Dec

The company has reinforced its American team to support its growth; EOS imaging (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging has announced its commercial and organizational expansion to support the momentum of installations in adult and pediatric hospitals in the United States. EOS imaging’s technical support team,... Read more

IMAGING Management

EOS Imaging Announces New Installation at a Leading Hospital in Japan

2015 05 Nov

Installation at Kudanzaka Hospital provides the EOS imaging platform to the highest volume hospital for spine surgery  EOS imaging (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging has announced a new installation of the EOS system at Kudanzaka Hospital, providing an exciting opportunity for the platform to benefit more... Read more

Jobs not available

Catalogue

    Catalogue not available

rue Mercoeur, 10
Paris
75011
France
+33/1/55256070

White Papers - Case Studies

Not available

Articles

Not available


MARIE MEYNADIER

CEO

Marie Meynadier has over 25 years of experience int the high tech and medical device Industries. After receiving her doctorate, she joined Bellcore (Red Bank, NJ) and ATT Bell Labs (Murray Hill, NJ), where she conducted research on semiconductor devices. She then returned to France to lead the management of major national and international development programs in electronics, optics and microelectronics, which enabled the creation of several start-ups in these areas. Marie joined the medical field in 1999, taking leadership at the start-up Biospace lab, where she specialized in preclinical imaging and rapidly turned it into a profitable business. She has been exclusively dedicated to EOS imaging since 2008.

Marie holds a degree in Electronic Engineering from Sup Telecom and a PhD (Doctorate) from the Ecole Normale Supérieure.


PIERRE SCHWICH

Chief Financial Officer

Pierre Schwich brings over 20 years of experience in Financial Management for high growth companies in the healthcare and technology sectors. Pierre served as the CFO of Pharnext, where he successfully led the company’s initial public offering. Previously he also held the position of Financial and Legal Director of Oceasoft, a company specialized in connected sensors, CFO of Cellectis where he contributed to a private placement with U.S. investors, and previously with Genesys Conferencing, a public company listed in Paris and on the NASDAQ, with a strong activity in the U.S. He has developed an extensive experience in M&A, fund raising and LBO operations, and initially - from 1989 to 1995 - in private equity investments with 3i, as well as in financial and administrative team management.

Pierre has a degree from the Mines ParisTech Engineering School.


DIDIER SAINT-FELIX

Chief Operating Officier

Didier Saint Félix has over 30 years of experience in the research and development of innovative medical imaging systems. Didier began his career at the French National Center for Scientific Research (CNRS). In 1986, he joined General Electric Healthcare to develop the first 3D angiography system used with a 2D detector, a system that is now in daily clinical use. He then led GE's research and development on mammography, completely renewing the product line and introducing digital technology. Didier is also a specialist in the quality and regulations that apply to medical imaging. He joined EOS imaging in 2006 to adapt the EOS® prototype to an industrial and commercial setting and now manages the company's production and service activities.


MAURICE DELPLANQUE

Vice President of Engineering

Maurice Delplanque has over 20 years of experience in engineering in the healthcare market. He joined General Electric Healthcare in 1997 after his PhD. He contributed as a software developer, project leader and eventually team manager of the development of the first digital radiography of neurology and cardiovascular systems. He also is a Six Sigma Black Belt. Maurice joined EOS imaging in 2007 as Software Manager and is now Vice President Engineering.

Maurice has a Electrical Engineering degree a PhD in Artificial Intelligence and Robotics from Lille University.


ERIC MAULAVE

Vice President of Global Sales

Eric Maulavé has over 25 years of experience and began his career as business engineer for the IT and Multimedia sectors within the Philips Group. He subsequently held various international positions as Sales and Marketing Director in several high tech departments of the group. After two years in Hong Kong, he joined the Healthcare division of Philips in 2007 to lead the sales and marketing activities of radiology for EMEA, LATAM, APAC, then the Home Healthcare Solutions activity for emerging markets. Eric joined EOS imaging in 2012 and brings a strong background in international medical equipment sales.

Eric has an MBA in Finance from the University of Hartford in Connecticut, Massachusetts, USA.


MIKE LOBINSKY
President, EOS imaging North America
Mike Lobinsky brings over 19 years in Medical Device Development. Served as U.S. Vice President, Sales and Implementation – Robotics at Smith & Nephew, which he joined through their 2016 acquisition of Blue Belt Technologies, a global leader in surgical robotics. At Blue Belt, he served as Vice President, Sales, leading all sales related activities for the company’s Navio surgical system, which provides robotics-assistance in knee replacement surgery. From 2006 to 2013, Mr. Lobinsky served in roles of increasing responsibly at BioMedix Vascular Solution, most recently as Vice President, Sales and Marketing. He has also held sales, marketing and management positions at Stryker Imaging, BrainLAB and Dentsply.
Mike has a Bachelor’s degree in Economics and Business Administration from University of Wisconsin – River Falls.

JAMIE MILAS

Vice President of Global Marketing

Jamie Milas has over 14 years of experience in the marketing of technical products and services. Prior to joining EOS imaging, she was Global Marketing Manager at Materialise, a Belgium-based company publically traded on the NASDAQ, where she led an international team promoting healthcare software and services B2B and B2C. She has marketed a vast portfolio of medical imaging and surgical planning software as well as 3D printed medical devices. Jamie joined EOS imaging in 2015 as the Vice President of Marketing.

Jamie has an MBA in Marketing and International Business from the University of Dayton in the United States.


ELISABETH SOUBELET

Chief Medical Officer

Elisabeth Soubelet has over 20 years of experience in the field of medical imaging in an international environment. She started her carrier in 1989 at General Electric Healthcare where she has held successive key positions in development, then clinical affairs in neuroradiology, mammography, cardiac electrophysiology and cardiology. Elisabeth joined EOS imaging in 2014.

Elisabeth has a Electrical Engineering degree from Angers Medical School, and a PhD (Doctorate) from the University of Paris VII.


BERNARD ISMAEL

Regulatory and Equality Affairs Director

Bernard Ismael has over 20 years of experience in the medical device industry. He has held several senior positions at Coloplast, then at Medtronic. He joined Boston Scientific in 2009 where he managed quality for the international market, and he played a significant role in the integration of companies newly acquired. Bernard joined EOS imaging in 2015 as the Director of Quality Regulatory Affairs.

Bernard has a Electrical Engineering degree from Ecole Nationale des Arts et Métiers (ENSAM) and a Master’s in Biomechanics.

GÉRARD HASCOËT

Chairman of the Board

Gérard Hascoët began his career in the medical technology business of Thomson CGR. As a serial entrepreneur, in 1985, he founded Technomed International, which is now a part of EDAP TMS, a Company dedicated to non-invasive medical treatment in urology. In 1993, he founded Sometec, a hemodynamic monitoring company acquired by Arrow International, and IMMI, a neurosurgical robotics company acquired by ISS. From 2008 to 2011, Gérard was CEO of SpineVision, a spinal implant company, and he continues to serve on the company’s Board of Directors. In 2009, he co-founded MD Start, a European incubator for medical technology companies, where he holds the position of Executive Chairman. Gérard is also a Venture Partner of Sofinnova, one of the leading European healthcare venture capital firms.

Gérard holds a degree in engineering from E.C.E Paris.


MARIE MEYNADIER

CEO and Board Member

Marie Meynadier has over 25 years of experience in the high tech and medical device Industries. After receiving her PhD, she joined Bellcore (Red Bank, NJ) and ATT Bell Labs (Murray Hill, NJ), where she conducted research on semiconductor devices. She then returned to France to lead the management of major national and international development programs in electronics, optics and microelectronics, which enabled the creation of several start-ups in these areas. Marie joined the medical field in 1999, taking leadership at the start-up Biospace lab, where she specialized in preclinical imaging and rapidly turned it into a profitable business. She has been exclusively dedicated to EOS imaging since 2008.

Marie holds a degree in Electronic Engineering from Sup Telecom and a PhD (Doctorate) from the Ecole Normale Supérieure.


MARIE-LAURE GARRIGUES

Board Member

Marie Laure Garrigues is the Director of Investments at Bpifrance. She started her career in Sanofi Diagnostics Pasteur, where she had various managerial responsibilities in R&D and marketing as the Direction of Operations. She next served as the Director of Microbiology in Bio-Rad laboratories, a California based company that develops diagnostic products.

Marie-Laure Garrigues is trained as a pharmacist and a former intern in medical biology. She holds a master’s degree in Pharmacy in Paris V University.


STÉPHANE SALLMARD

Board Member

Stéphane Sallmard started his career as a System Engineer at IBM France. He then served as Commercial and Service Director at Wang France, as well as being the Northern Europe Director of General Electric Medical Systems. While the Chief Executive Officer and director at Optos Plc, Stéphane received numerous technology awards.

Stéphane holds a diploma from Ecole Supérieure d’Electricité Industrielle de Paris.


ERIC BEARD

Board Member

Eric Beard joined Baxter Healthcare in 1975, where he pursued an international career, principally in North America, Asia Pacific and Europe. He held various positions of increasing responsibility in finance and later was in charge of Baxter's renal products in various countries and regions. In 1999, Eric assumed global responsibility for the dialysis business as President. In 2001, he was appointed President of Baxter EMEA. He joined Sorin Group in 2003 as International President in charge of worldwide sales and marketing. Eric is currently Chairman of Cellnovo.

Eric holds a degree in engineering from E.C.E Paris.


PAULA NESS SPEERS

Board Member

Paula Ness Speers has more than 30 years of experience in strategic and operational consulting for health-sector companies in the United States, including 7 years with Bain Company, where she was responsible for innovative technologies. In 1992, she co-founded Health Advances, a strategic consultancy firm devoted to the health sector and which has 100 staff based between Boston, San Francisco, Washington and Zurich to focus on the development of innovative companies. Paula has substantial expertise in analyzing the value of healthcare products and market access in the United States.

Paula has an MBA from Columbia University in the United States.


Clinical Partners

EOS is the result of strong interactions with orthopedic surgeons and radiologists, who shared with EOS engineers their dissatisfaction with the dose and diagnostic information available through standard CT and X-ray exams. Amongst them was Pr. Jean Dubousset, one of the twentieth century’s most famous spinal deformity surgeons. Today, EOS imaging nurtures a strong collaboration with clinical research teams in dozens of top-ranked hospitals around the world on topics that range from musculoskeletal radiology and dose reduction to advanced orthopedic applications based on 3D personalized patient models.


Academic Partners

EOS imaging maintains long-term collaborative relationships with several leading institutions such as ENSAM ParisTech Human Biomechanics Institute Georges Charpak in Paris, the lmaging and Orthopedics Research Laboratory of the Ecole de Technologie Supérieure (ETS) in Montreal, Telecom ParisTech's Laboratory of Excellence for imaging processing and others, and is an active member of the Competitiveness Cluster MEDICEN Ile de France. EOS is a supporting partner of several French and European collaborative research projects, some of which include FP7, Eurostars, FUI and ANR Tecsan.



THE EOS PLEDGE


Challenge the status quo in orthopedic imaging!
Demand 3D precision at a low dose!
Champion a new patient-specific standard of care!

WHY TAKE THE EOS PLEDGE?

Quality healthcare is of paramount importance to all of us! By taking The EOS Pledge, you are telling the world that you demand a new patient-specific standard of care. Your Pledge demonstrates your commitment to safe and accurate solutions for treating orthopedic conditions.

Supporting the guiding principles of The EOS Pledge is a first step towards a new era of personalized care that challenges the status quo and ensures that your voice is heard. Please join us in this important movement.

Jamie Milas explains the EOS Pledge - Watch the Video